Condition
Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive clinical trials that are recruiting, at sites in 14 countries (most in United States (2), Australia (1), Belgium (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 14Countries
All recruiting trials (2)
-
CMV Triplex vaccine to boost immunity and prevent CMV after haploidentical stem cell transplant
This trial tests whether giving a CMV-MVA Triplex vaccine to donors and/or recipients, with or without the antiviral letermovir, can boost CMV immunity and prevent CMV viremia in people having haploidentical stem cell transplants.
-
Evaluating ELVN-001 for treating Chronic Myeloid Leukemia
This study is testing a new treatment called ELVN-001 for people with chronic myeloid leukemia who haven't responded well to current therapies, to see if it can help them better.
Related topics
Quick answers
How many Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (2 trials), Australia (1 trial), Belgium (1 trial), Canada (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.